Emily Spivak Appointed to Serve on CDC's Board of Scientific Counselors
Aug 20, 2019 10:30 AM
Emily Spivak Appointed to Serve on CDC's Board of Scientific Counselors for the Office of Infectious Diseases
Dr. Emily Spivak, MD, MHS has been appointed by Alex Azar, United States Secretary for Health and Human Services, to serve on the Center for Disease Control and Prevention's (CDC) Board of Scientific Counselors for the Office of Infectious Diseases starting in the fall of 2019. This is a huge honor for Dr. Spivak, the Division of Infectious Diseases and the Department of Internal Medicine. Congratulations, Dr. Spivak!
About the CDC's Board of Scientific Counselors for the Office of Infectious Diseases
The Board of Scientific Counselors (BSC), Office of Infectious Diseases (OID), is one of CDC’s federal advisory committees, which work to achieve stakeholder and public engagement in CDC’s efforts and commitment to improve people’s health. CDC’s infectious disease BSC was originally established in 1962, making it one of the agency’s oldest advisory committees.
The BSC, OID, advises the Secretary, Department of Health and Human Services; the Director, CDC; the CDC Deputy Director for Infectious Diseases; and the Directors of CDC’s three infectious disease national centers concerning strategies, goals, and priorities for the programs and research within the national centers and monitors the overall strategic direction and focus of OID and the national centers.
About Dr. Emily Spivak
Dr. Spivak is an associate professor of Medicine, Division of Infectious Diseases and Medical Director of the Antimicrobial Stewardship Programs at University of Utah Health and the Salt Lake City VA. She came to Utah in 2011 after completing residency and fellowship training at the Johns Hopkins University School of Medicine. As Director of Antimicrobial Stewardship, she and her team assist clinicians with optimizing the selection of antibiotics, developing guidelines to promote the appropriate and judicious use of antibiotics, and monitoring patient outcomes after implementation of these practices. She is involved with clinical research evaluating antibiotic prescribing practices and opportunities for improvement, and patient outcomes related to various antibiotic use strategies. She is a member of the Society of Healthcare Epidemiology (SHEA), a Fellow of the Infectious Diseases Society of America (IDSA), and serves as the Vice Chair of the IDSA Antimicrobial Resistance Committee.